Search Within

Sloan Kettering Institute Postdocs

Formats
  1. Journal Article (8045)
  2. Meeting Abstract (3693)
  3. Review (630)
  4. Editorial (263)
  5. Book Section (195)
  6. Conference Paper (161)
  7. Research Letter (139)
  8. Correspondence (68)
  9. Miscellaneous (67)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. GSK Faculty (6365)
  2. Department of Medicine (4813)
  3. Sloan Kettering Institute Faculty (3571)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (3037)
  5. Surgery (2635)
  6. Solid Tumor Oncology Division (2607)

More Groups

People
  1. Britta Weigelt (376)
  2. Jorge Reis-Filho (328)
  3. Mithat Gonen (319)
  4. Marc Ladanyi (309)
  5. Michael Berger (288)
  6. Joseph Deasy (285)

More People

Years
  1. 2026 (1)
  2. 2025 (706)
  3. 2024 (1081)
  4. 2023 (1152)
  5. 2022 (1366)
  6. 2021 (1179)

More Years

Publications
  1. Blood (680)
  2. Cancer Research (543)
  3. Journal of Clinical Oncology (431)
  4. Journal of Nuclear Medicine (271)
  5. Annals of Surgical Oncology (264)
  6. Clinical Cancer Research (249)

More Publications

Publishers
  1. Nature Publishing Group (1350)
  2. Elsevier Inc. (1106)
  3. American Association for Cancer Research (1058)
  4. Springer (842)
  5. American Society of Hematology (740)
  6. Cell Press (740)

More Publishers

Results (13297)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interim efficacy analysis of a phase II study demonstrates promising activity of the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Sermer, D. J.; Vardhana, S.; Biggar, E.; Moskowitz, A. J.; Joffe, E.; Khan, N.; Straus, D. J.; Kumar, A.; Zelenetz, A. D.; Horwitz, S. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Monoclonal gammopathy of undetermined significance and COVID-19: Results from the population-based Iceland screens treats or prevents multiple myeloma study (iStopMM)
    Meeting Abstract

    Rögnvaldsson, S; Eythorsson, E.; Thorsteinsdottir, S.; Vidarsson, B.; Onudarson, P. T.; Agnarsson, B. A.; Sigurdardottir, M.; Horsteinsdottir, I.; Olafsson, I.; Runolfsdottir, H. L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Favorable outcomes of patients with limited-stage ocular adnexal DLBCL treated in the rituximab era: Long-term follow-up of a single center experience
    Meeting Abstract

    Qualls, D.; Batlevi, C. L.; Caron, P. C.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Khan, N.; Kumar, A.; Matasar, M. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • A comparison of clinical outcomes from updated ZUMA-5 (axicabtagene ciloleucel) and the international SCHOLAR-5 external control cohort in relapsed/refractory follicular lymphoma (R/R FL)
    Meeting Abstract

    Palomba, M. L.; Ghione, P.; Patel, A. R.; Deighton, K.; Jacobson, C.; Nahas, M.; Jung, A. S.; Hatswell, A. J.; Kanters, S.; Limbrick-Oldfield, E.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Tafasitamab plus lenalidomide versus pola-BR, R2, and CAR T: Comparing outcomes from RE-MIND2, an observational, retrospective cohort study in relapsed/refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Nowakowski, G. S.; Yoon, D. H.; Mondello, P.; Joffe, E.; Fleury, I.; Peters, A.; Greil, R.; Ku, M.; Marks, R.; Kim, K.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • A new role for the SRC family member HCK as a driver of BCR/SYK signaling in MYD88 mutated lymphomas
    Meeting Abstract

    Munshi, M.; Liu, X.; Kofides, A.; Tsakmaklis, N.; Demos, M. G.; Guerrera, M. L.; Hunter, Z. R.; Palomba, M. L.; Argyropoulos, K. V.; Patterson, C. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Graded cardiac response criteria for AL amyloidosis: The impact of depth of cardiac response on survival
    Meeting Abstract

    Muchtar, E.; Dispenzieri, A.; Wisniowski, B.; Palladini, G.; Milani, P.; Merlini, G.; Schönland, S.; Veelken, K.; Hegenbart, U.; Kumar, S.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Graded renal response criteria for light chain (AL) amyloidosis
    Meeting Abstract

    Muchtar, E.; Wisniowski, B.; Palladini, G.; Milani, P.; Merlini, G.; Schönland, S.; Veelken, K.; Hegenbart, U.; Dispenzieri, A.; Kumar, S.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • BTG1 mutation promotes aggressive lymphoma development by lowering the threshold to MYC activation and generating "super-competitor" B cells
    Meeting Abstract

    Mlynarczyk, C.; Teater, M.; Pae, J.; Arulraj, T.; Chin, C. R.; Wang, L.; Ersching, J.; Kots, E.; Chadburn, A.; Barin, E.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Clonotype-immunophenotype relationships in TET2 and IDH-mutant myeloid transformation
    Meeting Abstract

    Miles, L. A.; Bowman, R. L.; Delgaudio, N.; Robinson, T.; Carroll, M. P.; Meyer, S. E.; Levine, R. L.
    Blood (2021)

    Fulltext@MSK | Save